Skip to main content
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1999 Nov;90(11):1231–1237. doi: 10.1111/j.1349-7006.1999.tb00701.x

Somatic Mutations in RET Exons 12 and 15 in Sporadic Medullary Thyroid Carcinomas: Different Spectrum of Mutations in Sporadic Type from Hereditary Type

Shinya Uchino 1,, Shiro Noguchi 1, Hiroto Yamashita 1, Mari Sato 1, Mitsuo Adachi 1, Hiroyuki Yamashita 1, Shin Watanabe 1, Akira Ohshima 1, Shoshu Mitsuyama 2, Toshihide Iwashita 3, Masahide Takahashi 3
PMCID: PMC5926019  PMID: 10622534

Abstract

Germline mutations in the RET proto‐oncogene are responsible for multiple endocrine neoplasia type 2 (MEN 2A and 2B) and familial medullary thyroid carcinoma (FMTC). Point mutations or in‐frame deletions of exons 10, 11, 13, 14 and 16 are associated with sporadic medullary thyroid carcinoma (MTC). To understand further the role of the RET gene in sporadic MTC, we examined mutations in exons 12 and 15 of RET in patients with sporadic MTC. DNAs were extracted from 39 formalin‐fixed tumor tissues and corresponding normal thyroid tissues or peripheral blood leukocytes. DNA sequencing was used to identify mutations in exons 12 and 15 of RET. In this study, one novel somatic mutation was found in exon 12 and five novel mutations or deletions were found in exon 15. Of the patients with mutations, one had an in‐frame 12‐bp deletion (nt. 2625‐2636), one had point mutations in both codons 884 and 908, and the remaining three had point mutations in codons 748, 876 and 901, respectively. Together with our previous identification of somatic mutations in exons 10, 11, 13, 14 and 16, somatic alterations were found in 10 out of 39 (25.6%) sporadic MTCs. There was no association of RET gene mutations with tumor recurrence or prognosis. These results suggest that mutations occur frequently in the RET coding region in addition to the previously reported mutation hot spots, and there is a different spectrum of mutations between sporadic and hereditary MTC.

Keywords: Sporadic medullary thyroid carcinoma, RET gene, Point mutation, Multiple endocrine neoplasia, Tyro sine kinase domain

Full Text

The Full Text of this article is available as a PDF (119.8 KB).

REFERENCES

  • 1. ) Mulligan , L. M. , Kwok , J. B. J. , Healey , C. S. , Elsdon , M. J. , Eng , C. , Gardner , E. , Love , D. R. , Mole , S. E. , Moore , J. K. , Papi , L. , Ponder , M. A. , Telenius , H. , Tunnacliffe , A. and Ponder , B. A. J.Germ‐line mutations of the RET proto‐oncogene in multiple endocrine neoplasia type 2A . Nature , 363 , 458 – 460 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Goodfellow , P. J. and Wells , S. A. , Jr.RET gene and its implications for cancer . J. Natl. Cancer Inst. , 87 , 1515 – 1523 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 3. ) Takahashi , M. , Ritz , J. and Cooper , G. M.Activation of a novel human transforming gene, RET, by DNA rearrangement . Cell , 42 , 581 – 588 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Pierotti , M. A. , Santoro , M. , Jenkins , R. B. , Sozzi , G. , Bongarzone , I. , Grieco , M. , Monzini , N. , Miozzo , M. , Herrmann , M. A. , Fusco , A. , Hay , I. D. , Della Porta , G. and Vecchio , G.Characterization of an inversion on the long arm of chromosome 10 juxtaposing D10S170 and RET and creating the oncogenic sequence RET/PTC . Proc. Natl. Acad. Sci. USA , 89 , 1616 – 1620 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. ) Bongarzone , I. , Monzini , N. , Borrello , M. G. , Carcano , C. , Ferraresi , G. , Arighi , E. , Mondellini , P. , Della Porta , G. and Pierotti , M. A.Molecular characterization of a thyroid tumor‐specific transforming sequence formed by the fusion of RET tyrosine kinase and the regulatory subunit RIα of cyclic AMP‐dependent protein kinase A . Mol. Cell. Biol. 13 , 358 – 366 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. ) Bongarzone , I. , Butti , M. G. , Coronelli , S. , Borrello , M. G. , Santoro , M. , Mondellini , P. , Pilotti , S. , Fusco , A. , Della Porta , G. and Pierotti , M. A.Frequent activation of RET protooncogene by fusion with a new activating gene in papillary thyroid carcinomas . Cancer Res. , 54 , 2979 – 2985 ( 1994. ). [PubMed] [Google Scholar]
  • 7. ) Jhiang , S. M. , Smanik , P. A. and Mazzaferri , E. L.Development of a single‐step duplex RT‐PCR detecting different forms of RET activation, and identification of the third form of in vivo RET activation in human papillary thyroid carcinoma . Cancer Lett. , 78 , 69 – 76 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 8. ) Fugazzola , L. , Pierotti , M. A. , Vigano , E. , Pacini , F. , Vorontsova , T. V. and Bongarzone , I.Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post‐Chernobyl papillary thyroid cancer . Oncogene , 13 , 1093 – 1097 ( 1996. ). [PubMed] [Google Scholar]
  • 9. ) Klugbauer , S. , Demidchik , E. P. , Lengfelder , E. and Rabes , H. M.Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET‐fused gene RFG5 . Cancer Res , 58 , 198 – 203 ( 1998. ). [PubMed] [Google Scholar]
  • 10. ) Eng , C. , Clayton , D. , Schuffenecker , I. , Lenoir , G. , Cote , G. , Gagel , R. F. , van Amstel , H. K. P. , Lips , C. J. M. , Nishisho , I. , Takai , S. , Marsh , D. J. , Robinson , B. G. , Frank‐Raue , K. , Raue , F. , Xue , F. , Noll , W. W. , Romei , C. , Pacini , F. , Fink , M. , Niederle , B. , Zedenius , J. , Nordenskjöld , M. , Komminoth , P. , Hendy , G. N. , Gharib , H. , Thibodeau , S. N. , Lacroix , A. , Frilling , A. , Ponder , B. A. J. and Mulligan , L. M.The relationship between specific RET proto‐oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis . JAMA , 276 , 1575 – 1579 ( 1996. ). [PubMed] [Google Scholar]
  • 11. ) Berndt , I. , Reuter , M. , Saller , B. , Frank‐Raue , K. , Groth , P. , Grubendorf , M. , Raue , F. , Ritter , M. M. and Höppner , W.A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A . J. Clin. Endocrinol. Metab. , 83 , 770 – 774 ( 1998. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Hofstra , R. M. W. , Landsvater , R. M. , Ceccherini , I. , Stulp , R. P. , Stelwagen , T. , Luo , Y. , Pasini , B. , Höppener , J. W. M. , van Amstel , H. K. P. , Romeo , G. , Lips , C. J. M. and Buys , C. H. C. M.A mutation in the RET proto‐oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma . Nature , 367 , 375 – 376 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 13. ) Carlson , K. M. , Dou , S. , Chi , D. , Scavarda , N. , Toshima , K. , Jackson , C. E. , Wells , S. A. , Jr. , Goodfellow , P. J. and Donis‐Keller , H.Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B . Proc. Natl. Acad. Sci. USA , 91 , 1579 – 1583 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. ) Blaugrund , J. E. , Johns , M. J. , Eby , Y. J. , Ball , D. W. , Baylin , S. B. , Hruban , R. H. and Sidransky , D.RET protooncogene mutations in inherited and sporadic medullary thyroid cancer . Hum. Mol. Genet. , 3 , 1895 – 1897 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 15. ) Gimm , O. , Marsh , D. J. , Andrew , S. D. , Frilling , A. , Dahia , P. L. , Mulligan , L. M. , Zajac , J. D. , Robinson , B. G. and Eng , C.Germline dinucleotide mutation in codon 883 of the RET proto‐oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation . J. Clin. Endocrinol. Metab. , 82 , 3902 – 3904 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Smith , D. P. , Houghton , C. and Ponder , B. A. J.Germline mutation of RET codon 883 in two cases of de novo MEN 2B . Oncogene , 15 , 1213 – 1217 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Miyauchi , A. , Futami , H. , Hai , N. , Yokozawa , T. , Kuma , K. , Aoki , N. , Kosugi , S. , Sugano , K. and Yamaguchi , K.Two germline missense mutations at codons 804 and 806 of the RET proto‐oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation . Jpn. J. Cancer Res. , 90 , 1 – 5 ( 1999. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. ) Komminoth , P. , Kunz , E. K. , Matias‐Guiu , X. , Hiort , O. , Christiansen , G. , Colomer , A. , Roth , J. and Heitz , P. U.Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas . Cancer , 76 , 479 – 489 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 19. ) Kitamura , Y. , Goodfellow , P. J. , Shimizu , K. , Nagahama , M. , Ito , K. , Kitagawa , W. , Akasu , H. , Takami , H. , Tanaka , S. and Wells , S. A. , Jr.Novel germline RET proto‐oncogene mutations associated with medullary thyroid carcinoma (MTC): mutation analysis in Japanese patients with MTC . Oncogene , 14 , 3103 – 3106 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Eng , C. , Smith , D. P. , Mulligan , L. M. , Healey , C. S. , Zvelebil , M. J. , Stonehouse , T. J. , Ponder , M. A. , Jackson , C. E. , Waterfield , M. D. and Ponder , B. A. J.A novel point mutation in the tyrosine kinase domain of the RET protooncogene in sporadic medullary thyroid carcinoma and in a family with FMTC . Oncogene , 10 , 509 – 513 ( 1995. ). [PubMed] [Google Scholar]
  • 21. ) Bolino , A. , Schuffenecker , I. , Luo , Y. , Seri , M. , Silengo , M. , Tocco , T. , Chabrier , G. , Houdent , C. , Murat , A. , Schlumberger , M. , Tourniaire , J. , Lenoir , G. M. and Romeo , G.RET mutations in exons 13 and 14 of FMTC patients . Oncogene , 10 , 2415 – 2419 ( 1995. ). [PubMed] [Google Scholar]
  • 22. ) Fink , M. , Weinhäusel , A. , Niederle , B. and Haas , O. A.Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto‐oncogene . Int. J. Cancer , 69 , 312 – 316 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 23. ) Hofstra , B. M. W. , Fattoruso , O. , Quadro , L. , Wu , Y. , Libroia , A. , Verga , U. , Colantuoni , V. and Buys , C. H. C. M.A novel point mutation in the intracellular domain of the ret protooncogene in a family with medullary thyroid carcinoma . J. Clin. Endocrinol. Metab. , 82 , 4176 – 4178 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 24. ) Bugalho , M. J. , Frade , J. P. , Santos , J. R. , Limbert , E. and Sobrinho , L.Molecular analysis of the RET proto‐oncogene in patients with sporadic medullary thyroid carcinoma: a novel point mutation in the extracellular cysteine‐rich domain . Eur. J. Endocrinol. , 136 , 423 – 426 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 25. ) Romei , C. , Elisei , R. , Pinchera , A. , Ceccherini , I. , Molinaro , E. , Mancusi , F. , Martino , E. , Romeo , G. and Pacini , F.Somatic mutations of the RET protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence . J. Clin. Endocrinol. Metab. , 81 , 1619 – 1622 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 26. ) Donis‐Keller , H. , Dou , S. , Chi , D. , Carlson , K. M. , Toshima , K. , Lairmore , T. C. , Howe , J. R. , Moley , J. F. , Goodfellow , P. and Wells , S. A. , Jr.Mutations in the RET proto‐oncogene are associated with MEN 2A and FMTC . Hum. Mol. Genet. , 2 , 851 – 856 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 27. ) Hofstra , R. M. W. , Stelwagen , T. , Stulp , R. P. , de Jong , D. , Hulsbeek , M. , Kamsteeg , E. J. , van den Berg , A. , Landsvater , R. M. , Vermey , A. , Molenaar , W. M. , Lips , C. J. M. and Buys , C. H. C. M.Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases . J. Clin. Endocrinol. Metab. , 81 , 2881 – 2884 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Ceccherini , I. , Pacini , B. , Pacini , F. , Gullo , M. , Bongarzone , I. , Romei , C. , Santamaria , G. , Matera , I. , Mondellini , P. , Scopsi , L. , Pinchera , A. , Pierotti , M. A. and Romeo , G.Somatic in‐frame deletions not involving juxtamembranous cysteine residues strongly activate the RET proto‐oncogene . Oncogene , 14 , 2609 – 2612 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 29. ) Alemi , M. , Lucas , S. D. , Sällström , J. F. , Bergholm , U. , Åkerström , G. and Wilander , E.A complex nine base pair deletion in RET exon 11 common in sporadic medullary thyroid carcinoma . Oncogene , 14 , 2041 – 2045 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 30. ) Marsh , D. J. , Learoyd , D. L. , Andrew , S. D. , Krishnan , L. , Pojer , R. , Richardson , A. L. , Delbridge , L. , Eng , C. and Robinson , B. G.Somatic mutations in the RET proto‐oncogene in sporadic medullary thyroid carcinoma . Clin. Endocrinol. (Oxf) , 44 , 249 – 257 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Eng , C. , Mulligan , L. M. , Smith , D. P. , Healey , C. S. , Frilling , A. , Raue , F. , Neumann , H. P. H. , Pfragner , R. , Behmel , A. , Lorenzo , M. J. , Stonehouse , T. J. , Ponder , M. A. and Ponder , B. A. J.Mutation of the RET protooncogene in sporadic medullary thyroid carcinoma . Genes Chromosom. Cancer , 12 , 209 – 212 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Marsh , D. J. , Andrew , S. D. , Eng , C. , Learoyd , D. L. , Capes , A. G. , Pojer , R. , Richardson , A. L. , Houghton , C. , Mulligan , L. M. , Ponder , B. A. J. and Robinson , B. G.Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma . Cancer Res. , 56 , 1241 – 1243 ( 1996. ). [PubMed] [Google Scholar]
  • 33. ) Zedenius , J. , Larsson , C. , Bergholm , U. , Bovee , J. , Svensson , A. , Hallengren , B. , Grimelius , L. , Backdahl , M. , Weber , G. and Wallin , G.Mutations of codon 918 in the RET proto‐oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas . J. Clin. Endocrinol. Metab. , 80 , 3088 – 3090 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 34. ) Jhiang , S. M. , Fithian , L. , Weghorst , C. M. , Clark , O. H. , Falko , J. M. , O'Dorisio , T. M. and Mazzaferri , E. L.RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma . Thyroid , 6 , 115 – 121 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 35. ) Uchino , S. , Noguchi , S. , Adachi , M. , Sato , M. , Yamashita , H. , Watanabe , S. , Murakami , T. , Toda , M. , Murakami , N. and Yamashita , H.Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas . Jpn. J. Cancer Res. , 89 , 411 – 418 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. ) Uchino , S. , Noguchi , S. , Sato , M. , Adachi , M. , Yamashita , H. , Watanabe , S. , Murakami , T. , Toda , M. , Murakami , N. and Yamashita , H.RET gene analysis of latent small medullary thyroid carcinoma associated with Graves' disease . Thyroidol. Clin. Exp. , 10 , 279 – 281 ( 1998. ). [Google Scholar]
  • 37. ) Ceccherini , I. , Hofstra , R. M. W. , Luo , Y. , Stulp , R. P. , Barone , V. , Stelwagen , T. , Bocciardi , R. , Nijveen , H. , Bolino , A. , Seri , M. , Ronchetto , P. , Pasini , B. , Bozzano , M. , Buys , C. H. C. M. and Romeo , G.DNA polymorphisms and conditions for SSCP analysis of the 20 exons of the RET proto‐oncogene . Oncogene , 9 , 3025 – 3029 ( 1994. ). [PubMed] [Google Scholar]
  • 38. ) Komminoth , P. , Roth , J. , Muletta‐Feurer , S. , Saremaslani , P. , Seelentag , W. K. F. and Heitz , P. U.RET proto‐oncogene point mutations in sporadic neuroendocrine tumors . J. Clin. Endocrinol. Metab. , 81 , 2041 – 2046 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 39. ) Santoro , M. , Carlomagno , F. , Romano , A. , Bottaro , D. P. , Dathan , N. A. , Grieco , M. , Fusco , A. , Vecchio , G. , Matoskova , B. , Kraus , M. H. and Di Fiore , P. P.Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B . Science , 267 , 381 – 383 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 40. ) Xing , S. , Smanik , P. A. , Oglesbee , M. J. , Trosko , J. E. , Mazzaferri , E. L. and Jhiang , S. M.Characterization of RET oncogenic activation in MEN2 inherited cancer syndromes . Endocrinology , 137 , 1512 – 1519 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 41. ) Hanks , S. K. , Quinn , A. M. and Hunter , T.The protein kinase family: conserved features and deduced phylogeny of the catalytic domains . Science , 241 , 42 – 52 ( 1988. ). [DOI] [PubMed] [Google Scholar]
  • 42. ) Eng , C.The RET proto‐oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease . N. Engl. J. Med. , 335 , 943 – 951 ( 1996. ). [DOI] [PubMed] [Google Scholar]
  • 43. ) Borrello , M. G. , Smith , D. P. , Pasini , B. , Bongarzone , I. , Greco , A. , Lorenzo , M. J. , Arighi , E. , Miranda , C. , Eng , C. , Alberti , L. , Bocciardi , R. , Mondellini , P. , Scopsi , L. , Romeo , G. , Ponder , B. A. J. and Pierotti , M. A.RET activation by germline MEN2A and MEN2B mutations . Oncogene , 11 , 2419 – 2427 ( 1995. ). [PubMed] [Google Scholar]
  • 44. ) Komminoth , P. , Muletta‐Feurer , S. , Saremaslani , P. , Kunz , E. K. , Matias‐Guiu , X. , Hiort , O. , Schroder , S. , Seelentag , W. K. F. , Roth , J. and Heitz , P. U.Molecular diagnosis of multiple endocrine neoplasia (MEN) in paraffin‐embedded specimens . Endocr. Pathol. , 6 , 267 – 278 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 45. ) Shan , L. , Nakamura , M. , Nakamura , Y. , Utsunomiya , H. , Shou , N. , Jiang , X. , Jing , X. , Yokoi , T. and Kakudo , K.Somatic mutations in the RET protooncogene in Japanese and Chinese sporadic medullary thyroid carcinomas . Jpn. J. Cancer Res. , 89 , 883 – 886 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. ) Maeda , S. , Namba , H. , Takamura , N. , Tanigawa , K. , Takahashi , M. , Noguchi , S. , Nagataki , S. , Kanematsu , T. and Yamashita , S.A single missense mutation in codon 918 of the RET proto‐oncogene in sporadic medullary thyroid carcinomas . Endocr. J. , 42 , 245 – 250 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 47. ) Piao , X. , Paulson , R. , van der Geer , P. , Pawson , T. and Bernstein , A.Oncogenic mutation in the Kit receptor tyrosine kinase alters substrate specificity and induces degradation of the protein tyrosine phosphatase SHP‐1 . Proc. Natl. Acad. Sci. USA , 93 , 14665 – 14669 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. ) Webster , M. K. , d'Avis , P. Y. , Robertson , S. C. and Donoghue , D. J.Profound ligand‐independent kinase activation of fibroblast growth factor receptor 3 by the activation loop mutation responsible for a lethal skeletal dysplasia, thanatophoric dysplasia type II . Mol. Cell. Biol. , 16 , 4081 – 4087 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. ) Iwashita , T. , Kato , M. , Murakami , H. , Asai , N. , Ishiguro , Y. , Ito , S. , Iwata , Y. , Kawai , K. , Asai , M. , Kurokawa , K. , Kajita , H. and Takahashi , M.Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma . Oncogene , 18 , 3919 – 3922 ( 1999. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES